Affan Haleem is a Cardiology physician. OpenAlex indexes 10 publications with 437 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
307 S 13th St Ste 300
Mount Vernon, WA 982744100
Telephone
360-336-9757Provider last certified this registry record 9 Oct 2024.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20251 payment
- Philips North America LLCProgram year20251 payment
- CORDIS US CORP.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82%Beta blocker20.1%Metoprolol Succinate48%Carvedilol32%Metoprolol Tartrate20%Part D≥32 patientsStatin11.2%Atorvastatin Calcium75%Rosuvastatin Calcium25%Part D<11 patients+ 9 more classes in this area
Blood & clotting
10%P2Y12 inhibitor7.5%Clopidogrel65%Brilinta35%Part D<11 patientsFactor Xa inhibitor2.5%Eliquis100%Part D≥11 patientsMetabolism & gastrointestinal
7.9%SGLT2 inhibitor7.9%Jardiance52%Farxiga48%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- An Unlikely Cause of Chest Pain: Recurrent Takotsubo Cardiomyopathy
Journal of Community Hospital Internal Medicine Perspectives
2024 - INTERVENTION AND COMPLICATION ASSOCIATED WITH EPTIFIBATIDE USE IN STEMI PATIENTS:TERTIARY CENTRE RETROSPECTIVE STUDY
Journal of the American College of Cardiology
2024 - PILOT PROJECT USING PRINCIPAL CARE MANAGEMENT AND PA PRESSURE MONITORING TO ASSESS ITS EFFECT ON HEART FAILURE READMISSION AND HEALTHCARE BURDEN
Journal of the American College of Cardiology
2024 - MORTALITY AND READMISSION TREND OF HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION BASED ON HOME-HOSPITAL DISTANCE: AN ANALYSIS OF APPALACHIAN REGIONAL HEARTY FAILURE REGISTRIES
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”